Billings, MT - January 26, 2026 - PRESSADVANTAGE - Patients seeking expert care for glaucoma in the region are turning ...
Medical Device Network on MSN
Myra Vision enrols first patient in trial of Calibreye glaucoma system
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.
ALEXANDRIA, MN - January 24, 2026 - PRESSADVANTAGE - Individuals living with or at risk for glaucoma in the region can ...
The MarketWatch News Department was not involved in the creation of this content.-- Initial case conducted by Dr. David Godfrey at Glaucoma Associates of Texas -- The IDE study wi ...
Glaucoma continues to be one of the most significant causes of vision loss across the country, often developing slowly and without obvious warning signs. Frequently called the “silent thief of sight,” ...
Most of us don’t think much about our eyes unless something feels off. A headache, a fever, or even blurry vision can send us straight to a doctor, bu.
Glaucoma is scary for one simple reason, it doesn’t warn you before it starts taking your vision away. Most eye problems give ...
(Dr. Rita Dash) Glaucoma has a reputation as the "silent thief of sight," and for good reason. It is one of the leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results